All News

Oncology nurses have the power to heal, and in many cases, the power to inspire their patients no matter their age.

Talking about cancer can be a great burden but sharing one’s story can be liberating. Even if you share it while fishing.

Mary Schueller devoted her entire career to helping others with cancer, and the devotion she displayed to that cause is what makes her an extraordinary healer.

One patient recounts how his oncology nurse's love for healing helped him on his treatment journey.

In this special hematology focused issue of CURE® we look at all the promising treatments and research for both adults and children with blood cancers.

Mantle Cell Lymphoma (MCL), as described in this issue of CURE®, has an interesting and inspiring story. It was one of the first cancers known to have a genetic abnormality-chromosomal translocation t(11;14).

Remember, knowledge is power. The more information you have about your cancer, the less power it has over you.

From a new study showing that the iCanQuit smoking cessation app is more likely to work than typical guidelines, to the House unanimously passing the Veteran’s Prostate Cancer Treatment and Research Act, here’s what’s happening in the cancer landscape this week.

Oncology nurses are there for many moments on the cancer journey and can help champion important milestones that might otherwise go by unnoticed.

Finding the best care team can make all the difference for patients with diseases like multiple myeloma.

Clinical trials lead to new cancer treatments — and can give a patient access to effective drugs years before they’re made available to the public.

You know yourself best, so try and figure out what works best for you and do not be afraid to give yourself the precious gift of self-care during and after your cancer journey. You deserve this.

In this week’s episode of the CURE® Talks Cancer podcast, we chat with Dr. Tanja Gruber, the chief of pediatric hematology, oncology and stem cell transplantation at Stanford Children’s Health, about how pediatric cancer treatment is evolving thanks to advances in treatments like immunotherapy, and what parents should do after their child receives a diagnosis.

Here is a list of some recent trials that launched within the cancer space in September.

There is no approved treatment that targets the KRAS p.G12C mutation that drives some cancers like non-small cell lung cancer. But a recent study shows how the experimental drug sotorasib sparked responses in some patients with advanced non-small cell lung cancer that harbored the mutation.

For years, childhood blood cancers were understudied forcing patients’ treatments into a one size-fits-all approach. But new efforts are changing that.

I suffered a recurrence a few years ago and couldn’t bear to hear, or utter, the word “cancer.” So, I decided to counter-attack by belittling the disease and calling it “chocolate.” Then, I got my sweet revenge.

Weighing the cost of CAR-T cell therapy in treating blood cancers is a finical burden for many patients with blood cancer.

The PARP inhibitor Lynparza reduced the risk for death by 31% in men with metastatic castration-resistant prostate cancer compared with Xtandi or Zytiga plus the corticosteroid prednisone.

Findings from a randomized phase 3 study showed that adding neoadjuvant Tecentriq to a chemotherapy regimen of Abraxane, Adriamycin and Cytoxan in patients with stage 2 or 3 triple-negative breast cancer significantly improved pathologic complete responses, compared with placebo plus chemotherapy.

Exciting advances in treatment options for patients with mantle cell lymphoma are greatly improving the outlook for long-term remissions.

There are some amazing studies that show how certain birds help each other in times of need. For us cancer survivors, we should be like these birds and help each other more.

CAR-T Cell therapy is expanding in the field of blood cancers, but it comes with a host of side effects patients need to look out for. One study is looking to get ahead of the side effect curve for patients about to undergo CAR-T cell therapy.

In the winning essay for the Finest Hour award, Evangelina SantaTeresa, CCRN, details how the human touch makes all the difference for award winner Elizabeth “Liz” Farrat, B.S.N., CCRN at Memorial Sloan Kettering Cancer Center.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Thursday, September 24, at 1 p.m. EST, when we plan on discussing living with cancer, from mental health through treatment, to cancer-related pain and beyond.

On social media, CURE® recently asked its readers to share how they deal with the cognitive dysfunction that can come about from cancer treatment.

The greatest obstacle facing men with breast cancer may be … ourselves.

An oncology nurse outlines ways that patients can prevent dental erosion after a vomiting episode.

You have a new cancer diagnosis that stops you in your tracks. You are sick, afraid, vulnerable and in pain when you come to the cancer center at Temple University Hospital. The first advocate you will meet on your cancer journey is your nurse navigator

In a finalist essay, Laurie Loe details why Vicki Dodson, B.S.N., RN, OCN, is an extraordinary healer and a great mentor.